Sort by
Refine Your Search
-
Listed
-
Employer
- Delft University of Technology (TU Delft)
- Delft University of Technology (TU Delft); Delft
- University of Groningen
- Utrecht University
- Amsterdam UMC
- CWI
- Delft University of Technology (TU Delft); today published
- Maastricht University (UM)
- Maastricht University (UM); Maastricht
- Nature Careers
- Princess Máxima Center for Pediatric Oncology
- Princess Máxima Center for Pediatric Oncology; Utrecht
- Radboud University
- Royal Netherlands Academy of Arts and Sciences (KNAW)
- Royal Netherlands Academy of Arts and Sciences (KNAW); Utrecht
- The Netherlands Cancer Institute
- The Netherlands Cancer Institute; Amsterdam
- University of Groningen; Groningen
- Vrije Universiteit Amsterdam (VU)
- 9 more »
- « less
-
Field
-
The EVOLF consortium aims to create a living cell bottom up. This groundbreaking endeavour requires careful alignment with societal values and effective goverance. Job description The development of a
-
The EVOLF consortium aims to create a living cell bottom up. This groundbreaking endeavour requires careful alignment with societal values and effective goverance. Job description The development
-
of understanding disease mechanisms and developing innovative therapeutic strategies. As part of our team, you will leverage state-of-the-art single-cell, spatial, and organoid technologies in a collaborative and
-
that predispose to liver cancer, with the overarching goal of understanding disease mechanisms and developing innovative therapeutic strategies. As part of our team, you will leverage state-of-the-art single-cell
-
part of our team, you will leverage state-of-the-art single-cell, spatial and organoid technologies in a collaborative and interdisciplinary environment. Research focus We welcome candidates with a
-
Postdoc in Stem Cell Technology and Biofabrication Faculty: Faculty of Veterinary Medicine Department: Department Clinical Sciences Hours per week: 36 to 40 Application deadline: 1 August 2025
-
of RNA therapeutics for the brain. The successful candidate will work at the interface of molecular biology, cell models of the blood–brain barrier, and advanced human in vitro systems such as induced
-
work at the interface of molecular biology, cell models of the blood–brain barrier, and advanced human in vitro systems such as induced pluripotent stem cell (iPSC)-derived cultures and organoids. A key
-
aging-associated mechanisms and the development of RNA therapeutics for the brain. The successful candidate will work at the interface of molecular biology, cell models of the blood–brain barrier, and
-
the mechanisms that unfold these alternative DNA structures and identify the proteins involved. Our approach will combine this state-of-the-art biochemistry with cell biology, mass spectrometry, and high